These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 70265)

  • 1. Serum alpha-fetoprotein levels after hepatic artery ligation and postoperative chemotherapy: correlation with clinical status in patients with hepatocellular carcinoma.
    Nagasue N; Inokuchi K; Kobayashi M; Saku M
    Cancer; 1977 Aug; 40(2):615-8. PubMed ID: 70265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of hepatoma chemotherapy by alpha-fetoprotein determination.
    Matsumoto Y; Suzuki T; Ono H; Nakase A; Honjo I
    Am J Surg; 1976 Sep; 132(3):325-8. PubMed ID: 60886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in serum α-fetoprotein level predicts treatment response and survival in hepatocellular carcinoma patients and literature review.
    Chou WC; Lee CL; Yang TS; Huang CY; Teng W; Tseng YT; Chen JS; Lin YC; Hou MM; Chang HH; Chia-Hsun Hsieh J
    J Formos Med Assoc; 2018 Feb; 117(2):153-163. PubMed ID: 28392193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deletion of serum lectin-reactive alpha-fetoprotein by acyclic retinoid: a potent biomarker in the chemoprevention of second primary hepatoma.
    Moriwaki H; Yasuda I; Shiratori Y; Uematsu T; Okuno M; Muto Y
    Clin Cancer Res; 1997 May; 3(5):727-31. PubMed ID: 9815742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevation of alpha-fetoprotein level without evidence of recurrence after hepatectomy for hepatocellular carcinoma.
    Ezaki T; Yukaya H; Ogawa Y; Chang YC; Nagasue N
    Cancer; 1988 May; 61(9):1880-3. PubMed ID: 2451558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum alpha-fetoprotein level per tumor volume reflects prognosis in patients with hepatocellular carcinoma after curative hepatectomy.
    Furihata T; Sawada T; Kita J; Iso Y; Kato M; Rokkaku K; Shimoda M; Kubota K
    Hepatogastroenterology; 2008; 55(86-87):1705-9. PubMed ID: 19102374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postoperative serum alpha-fetoprotein level is a useful predictor of recurrence after hepatectomy for hepatocellular carcinoma.
    Nobuoka D; Kato Y; Gotohda N; Takahashi S; Nakagohri T; Konishi M; Kinoshita T; Nakatsura T
    Oncol Rep; 2010 Aug; 24(2):521-8. PubMed ID: 20596642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of curability and prediction of prognosis after surgical treatment for hepatocellular carcinoma by lens culinaris agglutinin-reactive alpha-fetoprotein.
    Okuda K; Tanaka M; Kanazawa N; Nagashima J; Satomura S; Kinoshita H; Eriguchi N; Aoyagi S; Kojiro M
    Int J Oncol; 1999 Feb; 14(2):265-71. PubMed ID: 9917501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sorafenib and hepatocellular carcinoma: is alpha-fetoprotein a biomarker predictive of tumor biology and primary resistance?
    Negri F; Gnetti L; Pedrazzi G; Silini EM; Porta C
    Future Oncol; 2021 Sep; 17(27):3579-3584. PubMed ID: 34155918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subclinical primary liver carcinoma.
    Li GH; Li JQ
    J Surg Oncol; 1989 Nov; 42(3):181-3. PubMed ID: 2478836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum alpha-fetoprotein estimations and doubling time in hepatocellular carcinoma: influence of therapy and possible value in early detection.
    Johnson PJ; Williams R
    J Natl Cancer Inst; 1980 Jun; 64(6):1329-32. PubMed ID: 6154822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Significance of Preoperative Hepatocellular Carcinoma With High
    Yamao T; Yamashita YI; Imai K; Umezaki N; Tsukamoto M; Kitano Y; Arima K; Miyata T; Nakagawa S; Okabe H; Hayashi H; Chikamoto A; Ishiko T; Baba H
    Anticancer Res; 2019 Feb; 39(2):883-889. PubMed ID: 30711971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum alpha-fetoprotein response as a surrogate for clinical outcome in patients receiving systemic therapy for advanced hepatocellular carcinoma.
    Vora SR; Zheng H; Stadler ZK; Fuchs CS; Zhu AX
    Oncologist; 2009 Jul; 14(7):717-25. PubMed ID: 19581525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The prognostic value of focusylated alpha-fetoprotein measurement in liver cancer patients after surgery].
    Yin ZF; Wu MC; Yu ZQ
    Zhonghua Wai Ke Za Zhi; 1994 Nov; 32(11):654-6. PubMed ID: 7539735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Half-life of serum alpha-fetoprotein: an early prognostic index of recurrence and survival after hepatic resection for hepatocellular carcinoma.
    Shim JH; Han S; Lee YJ; Lee SG; Kim KM; Lim YS; Chung YH; Lee YS; Lee HC
    Ann Surg; 2013 Apr; 257(4):708-17. PubMed ID: 23108121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serial serum AFP heterogeneity changes in patients with hepatocellular carcinoma during chemotherapy.
    Buamah PK; Cornell C; James OF; Skillen AW; Harris AL
    Cancer Chemother Pharmacol; 1986; 17(2):182-4. PubMed ID: 2424626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic roles of preoperative α-fetoprotein and des-γ-carboxy prothrombin in hepatocellular carcinoma patients.
    Meguro M; Mizuguchi T; Nishidate T; Okita K; Ishii M; Ota S; Ueki T; Akizuki E; Hirata K
    World J Gastroenterol; 2015 Apr; 21(16):4933-45. PubMed ID: 25945007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of early response to hepatic arterial infusion chemotherapy in patients with advanced hepatocellular carcinoma using the combination of response evaluation criteria in solid tumors and tumor markers.
    Miyaki D; Kawaoka T; Aikata H; Kan H; Fujino H; Fukuhara T; Kobayashi T; Naeshiro N; Honda Y; Tsuge M; Hiramatsu A; Imamura M; Hyogo H; Kawakami Y; Yoshimatsu R; Yamagami T; Awai K; Chayama K
    J Gastroenterol Hepatol; 2015 Apr; 30(4):726-32. PubMed ID: 25311578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Correlation between serum alpha-fetoprotein variant levels in patients with hepatocellular carcinoma and the presence of alpha-fetoprotein mRNA in the circulating blood].
    Kang XY; Yin ZF; Qian HH; Wu ZD; Yu ZX; Wu MC
    Zhonghua Gan Zang Bing Za Zhi; 2003 Jan; 11(1):17-9. PubMed ID: 12546734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Higher Ratio of Serum Alpha-Fetoprotein Could Predict Outcomes in Patients with Hepatitis B Virus-Associated Hepatocellular Carcinoma and Normal Alanine Aminotransferase.
    Kim YI; Kim HS; Park JW
    PLoS One; 2016; 11(6):e0157299. PubMed ID: 27304617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.